Scott Babington

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

David Ball, Shalini Vinod, Scott Babington et al. · The Lancet Oncology · 2019 · 584 citations

Medicine, Oncology, Radiation Oncology +13

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial

Edward Chow, Yvette M. van der Linden, Daniel Roos et al. · The Lancet Oncology · 2013 · 298 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial

Bryan Burmeister, Michael A. Henderson, Jill Ainslie et al. · The Lancet Oncology · 2012 · 293 citations

Medicine, Oncology, Surgery +17

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial

Michael A. Henderson, Bryan Burmeister, Jill Ainslie et al. · The Lancet Oncology · 2015 · 224 citations

Medicine, Oncology, Surgery +14

Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision?

Scott Babington, Michael Veness, Val Gebski et al. · ANZ Journal of Surgery · 2003 · 71 citations

Medicine, Oncology, Surgery +16